Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches

被引:0
|
作者
Bing Wu
Jie Sun
Shu-Pei Cheng
Ji-Dong Gu
Ai-Min Li
Xu-Xiang Zhang
机构
[1] Nanjing University,State Key Laboratory of Pollutant Control and Resource Reuse, School of the Environment
[2] The University of Hong Kong,Laboratory of Environmental Microbiology and Toxicology, School of Biological Sciences
来源
Ecotoxicology | 2011年 / 20卷
关键词
Cytochrome P450 2E1; Styrene; Homology modeling; Molecular docking; Mammal;
D O I
暂无
中图分类号
学科分类号
摘要
Cytochrome P450 2E1 (CYP2E1) is a cytochrome P450 enzyme involved in styrene metabolism. This study compared the binding affinities between styrene and 11 mammalian CYP2E1 systems using bioinformatics methods. Firstly, amino acid sequences of CYP2E1s were obtained from the Swiss-Prot database. Then, taking the crystal structure of human CYP2E1 as a template, 3D models of the CYP2E1s of other mammals were constructed using the SWISS-MODEL program. Finally, the generated homology models were applied to calculate their docking capacities against styrene and polystyrene using the Surflex-Dock program, which could automatically dock ligands into a receptor’s ligand binding site using a protomol based approach and assess the affinity by an empirically derived scoring function. Docking experiments showed that the studied mammalian CYP2E1s had high binding affinities with styrene. For polystyrene, the dimmer of styrene has high binding affinities with CYP2E1s, however, trimer and other high polymers were found hard to be docked into the CYP2E1s. The results of this study indicated that bioinformatics approaches might be useful tools to predict styrene and polystyrene affinities with mammalian CYP2E1s.
引用
收藏
页码:1041 / 1046
页数:5
相关论文
共 50 条
  • [21] Relationship between alcoholism and CYP2E1 C/D polymorphism
    Iwahashi, K
    Ameno, S
    Ameno, K
    Okada, N
    Kinoshita, H
    Sakae, Y
    Nakamura, K
    Watanabe, M
    Ijiri, I
    Harada, S
    NEUROPSYCHOBIOLOGY, 1998, 38 (04) : 218 - 221
  • [22] ETHANOL INDUCES CYP2E1 BY PROTEIN STABILIZATION - ROLE OF UBIQUITIN CONJUGATION IN THE RAPID DEGRADATION OF CYP2E1
    ROBERTS, BJ
    SONG, BJ
    SOH, Y
    PARK, SS
    SHOAF, SE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (50) : 29632 - 29635
  • [23] Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor
    Han, Zixinying
    Liu, Chenxu
    Li, Mingrui
    Deng, Mengyan
    Ding, Ying
    Li, Yunchao
    Huo, Meidan
    Xu, Haiwei
    Qiao, Hailing
    Gao, Na
    BIOCHEMICAL PHARMACOLOGY, 2024, 229
  • [24] Styrene and its metabolites exhibit potential for multiple-site interaction with CYP2E1
    Hartman, Jessica H.
    Boysen, Gunnar
    Miller, Grover P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [25] Metabolism and toxicity of the styrene metabolite 4-vinylphenol in CYP2E1 knockout mice
    Vogie, KM
    Mantick, NA
    Carlson, GP
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2004, 67 (02): : 145 - 152
  • [26] Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis
    Ye, Xiang-Hua
    Song, Liang
    Peng, Ling
    Bu, Zhibin
    Yan, Sen-Xiang
    Feng, Jie
    Zhu, Xin-Li
    Liao, Xin-Biao
    Yu, Xue-Lin
    Yan, Danfang
    MOLECULAR GENETICS AND GENOMICS, 2015, 290 (02) : 545 - 558
  • [27] Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis
    Xiang-Hua Ye
    Liang Song
    Ling Peng
    Zhibin Bu
    Sen-Xiang Yan
    Jie Feng
    Xin-Li Zhu
    Xin-Biao Liao
    Xue-Lin Yu
    Danfang Yan
    Molecular Genetics and Genomics, 2015, 290 : 545 - 558
  • [28] CYP2E1 and clinical features in alcoholics
    Nakamura, K
    Iwahashi, K
    Ameno, K
    Sekine, Y
    Suzuki, K
    Minabe, Y
    Mori, N
    NEUROPSYCHOBIOLOGY, 2003, 47 (02) : 86 - 89
  • [29] RELATIONSHIP IN HEALTHY-SUBJECTS BETWEEN CYP2E1 GENETIC POLYMORPHISMS AND THE 6-HYDROXYLATION OF CHLORZOXAZONE - A PUTATIVE MEASURE OF CYP2E1 ACTIVITY
    KIM, RB
    OSHEA, D
    WILKINSON, GR
    PHARMACOGENETICS, 1994, 4 (03): : 162 - 165
  • [30] CYP2E1 autoantibodies in liver diseases
    Sutti, Salvatore
    Rigamonti, Cristina
    Vidali, Matteo
    Albano, Emanuele
    REDOX BIOLOGY, 2014, 3 : 72 - 78